Exosomes from neuronal stem cells may protect the heart from ischaemia/reperfusion injury via JAK1/2 and gp130
Open Access
- 1 April 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (9) , 4455-4465
Abstract
Myocardial infarction requires urgent reperfusion to salvage viable heart tissue. However, reperfusion increases infarct size further by promoting mitochondrial damage in cardiomyocytes. Exosomes from a wide range of different cell sources have been shown to activate cardioprotective pathways in cardiomyocytes, thereby reducing infarct size. Yet, it is currently challenging to obtain highly pure exosomes in quantities enough for clinical studies. To overcome this problem, we used exosomes isolated from CTX0E03 neuronal stem cells, which are genetically stable, conditionally inducible and can be produced on an industrial scale. However, it is unknown whether exosomes from neuronal stem cells may reduce cardiac ischaemia/reperfusion injury. In this study, we demonstrate that exosomes from differentiating CTX0E03 cells can reduce infarct size in mice. In an in vitro assay, these exosomes delayed cardiomyocyte mitochondrial permeability transition pore opening, which is responsible for cardiomyocyte death after reperfusion. The mechanism of MPTP inhibition was via gp130 signalling and the downstream JAK/STAT pathway. Our results support previous findings that exosomes from non‐cardiomyocyte‐related cells produce exosomes capable of protecting cardiomyocytes from myocardial infarction. We anticipate our findings may encourage scientists to use exosomes obtained from reproducible clinical‐grade stocks of cells for their ischaemia/reperfusion studies.Keywords
Funding Information
- National Institute for Health Research
- British Heart Foundation (PG/19/51/34493)
- Medical Research Council (MR/N013867/1)
This publication has 57 references indexed in Scilit:
- How pure are your vesicles?Journal of Extracellular Vesicles, 2013
- Extracellular vesicle sizing and enumeration by nanoparticle tracking analysisJournal of Extracellular Vesicles, 2013
- Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced CardioprotectionCardiovascular Drugs and Therapy, 2012
- Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusionBasic Research in Cardiology, 2010
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsBlood, 2010
- Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?Journal of Molecular and Cellular Cardiology, 2009
- Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell lineBiotechnology Letters, 2009
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotectionThe International Journal of Biochemistry & Cell Biology, 2006
- Preconditioning protects by inhibiting the mitochondrial permeability transitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004